M
Michelle E. Roland
Researcher at Centers for Disease Control and Prevention
Publications - 60
Citations - 4811
Michelle E. Roland is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Transplantation & Liver transplantation. The author has an hindex of 30, co-authored 60 publications receiving 4517 citations. Previous affiliations of Michelle E. Roland include California Department of Public Health & San Francisco General Hospital.
Papers
More filters
Journal ArticleDOI
Relationship between T Cell Activation and CD4+ T Cell Count in HIV-Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy
Peter W. Hunt,Jason M. Brenchley,Elizabeth Sinclair,Joseph M. McCune,Michelle E. Roland,Kimberly Page-Shafer,Priscilla Y. Hsue,Brinda Emu,Melissa R. Krone,Harry Lampiris,Daniel C. Douek,Jeffrey N. Martin,Steven G. Deeks +12 more
TL;DR: HIV controllers have abnormally high T cell activation levels, which may contribute to progressive CD4(+) T cell loss even without measurable viremia.
Journal ArticleDOI
Guidelines for the Management of Chronic Kidney Disease in HIV-Infected Patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America
Samir K. Gupta,Joseph A. Eustace,Jonathan A. Winston,Ivy I. Boydstun,Tejinder S. Ahuja,Rudolph A. Rodriguez,Karen T. Tashima,Michelle E. Roland,Nora Franceschini,Frank J. Palella,Jeffrey L. Lennox,Paul E. Klotman,Sharon Nachman,Stephen D. Hall,Lynda A. Szczech +14 more
TL;DR: This research presents a meta-analysis of the immune system’s response to Epstein-Barr virus, which has the potential to improve the quality of life of patients and reduce the likelihood of adverse events.
Journal ArticleDOI
Outcomes of Kidney Transplantation in HIV-Infected Recipients
Peter G. Stock,Burc Barin,Barbara Murphy,Douglas W. Hanto,Jorge Diego,Jimmy A. Light,Charles E. L. B. Davis,Emily A. Blumberg,David Simon,Aruna Subramanian,J. Michael Millis,G. Marshall Lyon,Kenneth L. Brayman,Doug Slakey,Ron Shapiro,Joseph K. Melancon,Jeffrey M. Jacobson,Valentina Stosor,Jean L. Olson,Donald Stablein,Michelle E. Roland +20 more
TL;DR: In this cohort of carefully selected HIV-infected patients, both patient- and graft-survival rates were high at 1 and 3 years, with no increases in complications associated with HIV infection.
Journal ArticleDOI
Survival of Human Immunodeficiency Virus–Infected Liver Transplant Recipients
Margaret V. Ragni,Steven H. Belle,KyungAh Im,Guy W. Neff,Michelle E. Roland,Peter G. Stock,Nigel Heaton,Abhi Humar,John F. Fung +8 more
TL;DR: It is suggested that survival of HIV-positive liver transplant recipients does not differ from that ofAIDS-negative liver transplant recipient, and HIV infection should no longer be a contraindication to OLTX.
Journal ArticleDOI
HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes.
Michelle E. Roland,Burc Barin,Laurie Carlson,Lynda A. Frassetto,Norah A. Terrault,R. Hirose,Chris E. Freise,Leslie Z. Benet,Nancy L. Ascher,John P. Roberts,Barbara Murphy,M. J. Keller,Kim M. Olthoff,Emily A. Blumberg,Kenneth L. Brayman,Stephen T. Bartlett,Charles E. L. B. Davis,Joseph M. McCune,Barry M. Bredt,Donald Stablein,Peter G. Stock +20 more
TL;DR: Good transplant and HIV‐related outcomes among kidney transplant recipients, and reasonable outcomes among liver recipients suggest that transplantation is an option for selected HIV‐infected patients cared for at centers with adequate expertise.